International Market Access

The biosimilars pathway is critical for China's biotechnology industry – and this is evident in the investment the government is making in the manufacture of biotech products

For companies looking to partner in China, they must first realize the unique needs of this market.

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

What does the future hold for the biotechnology industry in Japan? The Japanese government has made great strides to boost biotech within its borders.

In this informative editorial Jim Greenwood, BIO President and CEO, presents an insight into China’s growing role in the future of biotechnology.

During this period of tremendous growth in both the Indian economy and its healthcare sector, it is a critical time to capitalize on the biotech opportunities available within India.

With more than one-fifth of the world’s population, China is an important market for biotech products and is increasingly a key global player in biotech research, development and manufacturing.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

Overhauled BIOTradeStatus lets users search for the latest information on hundreds of products.

Bringing biotechs into global health R&D.

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will lay the foundation for increased cooperation to help biotech flourish in China.

Brenda Herschbach Jarrell and Jennifer Groves present an overview of the IP landscape in China, India, Brazil and Korea.

Letters, Testimony & Comments

September 4 2012
BIO supports the President’s decision to include Mexico in the TPP trade negotiations. Providing effective intellectual property...
September 3 2012
I. Agricultural and Animal Biotechnology The Government of Canada has long been a trusted ally to the United States on agricultural...
August 16 2012
The Biotechnology Industry Organization (BIO) appreciates the U.S. Trade Representative's (USTR) query about BIO's views on how...
October 20 2011
By electronic submission   Mr. Stan McCoy Assistant USTR for Intellectual Property and Innovation Office of the U.S. Trade...
October 24 2010
Dear Governor Fortuño: In what is currently one of the worst economic recessions to be experienced in our lifetime, the life...

Press Releases

June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
October 5 2011
Washington, D.C. (October 5, 2011) – The Biotechnology Industry Organization (BIO) welcomed the transmission of...
January 10 2011
WASHINGTON, D.C. (Monday, January 10, 2011) - The Biotechnology Industry Organization (BIO) today announced the...
October 27 2010
WASHINGTON, D.C. (Wednesday, October 27, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
June 8 2010
WASHINGTON, D.C. (Tuesday, June 08, 2010) - The Biotechnology Industry Organization (BIO) announces a two-day annual...